Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-03-06
1994-03-29
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514444, 514474, 549 60, 549315, 549316, A61K 31365, C07D30762
Patent
active
052985261
ABSTRACT:
The present invention relates to a method for synthesis of optically pure stereogenically labile 4-substituted-2-hydroxytetronic acids from an asymmetric .alpha.-hydroxy ester. The chiron approach of the present invention utilizes a non-nucleophilic lithium amide base under kinetically controlled Claisen conditions to produce a 4-substituted-2-pheylmethoxy precursor to the 4-substituted-2-hydroxy tetronic acid. The invention further relates to the use of such optically pure compounds as potent inhibitors of platelet aggregation by working at the level of cyclooxygenase. The invention further relates to the pharmaceutical use of such compounds in the treatment of coronary artery diseases, especially in the treatment and/or prevention of atherosclerosis.
REFERENCES:
R. E. Ireland et al., J. Org. Chem., "An Approach to the Total Synthesis of Chlorothricolide," 44 (17), pp. 3041-3052 (1979).
G. Stork et al., J. Am. Chem. Soc., "Iterative Butenolide Construction of Polypropionate Chains," 109, pp. 1565-1567 (1987).
Y. S. Rao, Chemical Reviews,"Recent Advances in Chemistry of Unsaturated Lactones" 76 (5) pp. 625-694 (1976).
D. T. Witiak et al., J. Med. Chem., "Synthetic Aci-Reductones," 31 (7) pp. 625-694 (1976).
J. E. Wrobel, et al., J. Org. Chem., "Total Synthesis of (-)-Vertinolide," 48 (21) pp. 3761-3764 (1983).
P. Booth, et al., J. Chem. Soc. Perkin Trans I, "Preparation of Acyltetronic Acids . . . " pp. 121-129 (1987).
B. Helferich et al., Ber, "Fine Neue Ascoibinsaure Synthese," 70, pp. 465-468 (1937).
S. Brandange et al., J. Org. Chem., "Studies on Intramolecular Claisen Condensation," 49 pp. 928-931 (1984).
R. E. Ireland, J. Org. Chem., "Approach to the Total Synthesis of Chlorothricolide," 51(5), pp. 635-648 (1986).
F. Corey et al., "Advanced Organic Chemistry," Part B, 2nd ed., Plenum Press, New York (1983).
J. March, "Advanced Organic Chemistry," ed., pp. 104-107 John Wiley & sons, New York (1985).
J. Bloomer et al., J. Org. Chem., "Total Synthesis of .alpha.-Carboxymethyltetronic Acid" 39 113 (1974).
V. Komanna et al., Lipids, "Serum Lipoprotein and Apoprotein Concentrations in 4-(4-Chlorophenyl)-2-Hydroxytetronic Acid," 24(1) pp. 25-32 (1989).
G. Pattenden et al., Fortschr. Chem. Orig. Naturst., "Natural 4-Ylidenebutenolides and 4-Ylidenetetronic Acids," 35 pp. 133-139 (1978).
Berdy, "Handbook of Antibiotic Compounds," CRC, Boco Raton Fla., 1980, vol. II, p. 415.
R. T. Witiak et al., J. Med. Chem., "Hypocholesterolemic Acid Antiaggregatory Properties of 2-Hydroxytetronic Acid . . . " 25 (1), pp. 90-93 (1982).
J. Whitesell et al., J. Org. Chem., "Resolution of Chiral Alcohols With Mandelic Acid," 48(20) pp. 3548-3551 (1983).
M. Gore, J. Org. Chem., "Oxidation of Enolates by Dibenzyl Peroxydicarbonate to Carbonates . . . ,"0 51 (19) 3700-3704 (1986).
D. Evans et al., Tetrahedron,"The Asymmetric Synthesis of .alpha.-Amino and .alpha.-Hydrozino Acid Derivatives . . . " 44 (17) pp. 5525-5540 (1988).
Tehim Ashok K.
Witiak Donald T.
Raymond Richard L.
The Ohio State University Research Foundation
LandOfFree
Optically pure stereogenically labile 4-substituted-2-hydroxytet does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optically pure stereogenically labile 4-substituted-2-hydroxytet, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically pure stereogenically labile 4-substituted-2-hydroxytet will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-792185